Corvus Pharmaceuticals: Now At Cruising Altitude

Over the last nine months since we last took a look at them, plucky little startup pharma Corvus Pharmaceuticals (NASDAQ: CRVS ) has been plugging along, releasing fresh rounds of data, business and clinical, that sent theHello! We're Derek and Betsy, a husband-and-wife investment duo. Our experiences include academia, fintech, software engineering, manufacturing and corporate finance. We're value investors who know our circle of competence and have a healthy appreciation for macroeconomic trends. We're als ...